转录因子同源盒D9通过直接结合人乳头瘤病毒癌基因启动子参与宫颈癌恶性表型
研究检测100例宫颈癌组织、多种宫颈癌细胞系及人肿瘤异种移植小鼠模型,发现HOXD9在宫颈癌中表达升高且与淋巴血管间隙浸润和淋巴结转移正相关;敲低HOXD9可抑制细胞增殖、迁移、侵袭并诱导凋亡,直接结合HPV16 E6/E7的P97启动子抑制其表达,作者认为HOXD9可能作为预后生物标志物和潜在治疗靶点。
要点
- 宫颈癌细胞系均表达HOXD9 mRNA和蛋白,宫颈癌组织中HOXD9基因表达显著高于正常宫颈组织
- HOXD9高表达与淋巴血管间隙浸润和淋巴结转移呈正相关
- 敲低HOXD9直接结合HPV16 E6/E7的P97启动子抑制其表达,并上调P53蛋白
核心结论
- HOXD9通过直接结合P97启动子促进HPV16 E6和E7表达,增强宫颈癌细胞的增殖、迁移和转移。
- 作者认为HOXD9可能作为宫颈癌的预后生物标志物和潜在治疗靶点。
研究设计与样本
- 研究使用100例宫颈癌(CC)病例、宫颈癌细胞系SKG-I、SKG-II、SKG-IIIa、SKG-IIIb、HeLa和SiHa以及人肿瘤异种移植小鼠模型。
- 采用RNA干扰敲低HOXD9,应用qPCR、功能实验、western blotting、DNA微阵列以及荧光素酶和ChIP实验进行评估。
主要发现
- 所有宫颈癌细胞系均表达HOXD9 mRNA和蛋白。
- 在子宫宫颈癌中,HOXD9基因表达显著高于正常宫颈组织。
- 患者样本中发现淋巴血管间隙浸润和淋巴结转移与HOXD9高表达呈正相关。
- 小鼠异种移植模型中HOXD9敲低细胞仅形成小肿瘤或无肿瘤。
- 敲低HOXD9显著降低宫颈癌细胞增殖、迁移和侵袭,诱导凋亡,增加P53蛋白表达,并通过直接结合HPV16 E6/E7基因的P97启动子抑制HPV E6/E7表达。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine the involvement of homeobox D9 (HOXD9) in the survival, proliferation, and metastasis of cervical cancer cells through regulating the expression of human papillomavirus (HPV) 16 E6/E7 genes using the P97 promoter. METHODS: One hundred cases of cervical cancer (CC), CC cell lines SKG-I, SKG-II, SKG-IIIa, SKG-IIIb, HeLa, and SiHa, and a human tumor xenograft mouse model were used to examine the roles of HOXD9 in CC. Knockdown experiments employed RNA interference of HOXD9. qPCR, functional assays, western blotting, DNA microarray, and luciferase and ChIP assays were applied for assessments. RESULTS: All CC cell lines expressed HOXD9 mRNA and protein. In uterine CC, HOXD9 gene expression was significantly higher than in normal cervical tissues. A positive correlation of lymphovascular space invasion and lymph node metastasis with high levels of HOXD9 expression was found in patient samples. HOXD9-knockdown cells in the mouse xenograft model only formed small or no tumors. Knockdown of HOXD9 markedly reduced CC cell proliferation, migration and invasion, induced apoptosis, increased P53 protein expression, and suppressed HPV E6/E7 expression by directly binding to the P97 promoter of HPV16 E6/E7 genes. A positive correlation between HOXD9 and HPV16 E6 expression was found in CC patients. CONCLUSIONS: HOXD9 promotes HPV16 E6 and E7 expression by direct binding to the P97 promoter, which enhances proliferation, migration, and metastasis of CCr cells. Our results suggest that HOXD9 could be a prognostic biomarker and potential therapeutic target in CC.
引用
- Hirao N, Iwata T, Tanaka K, et al. Transcription factor homeobox D9 is involved in the malignant phenotype of cervical cancer through direct binding to the human papillomavirus oncogene promoter. Gynecol Oncol. 2019. PMID: 31477279. doi:10.1016/j.ygyno.2019.08.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。